FDA Reviews Esophageal Cancer Risk from Fosamax, Other Bone Drugs
Some oral osteoporosis drugs, known as bisphosponates, may increase the risk of esophageal cancer, according to a statement issued by the FDA.
July 22, 2011 By: Staff Writers
Some oral osteoporosis drugs, known as bisphosponates, may increase the risk of esophageal cancer, according to a statement issued by the FDA.
Eight women have filed Uber sexual assault lawsuits, claiming the rideshare service failed to protect them from predatory drivers due to its lack of safety measures.
A new report highlights how many women and families feel left out of Camp Lejeune settlement negotiations after suffering repeated miscarriages they say were caused by miscarriages on the North Carolina military base.
A Bard Infuse-A-Port lawsuit claims a piece of a failed port catheter broke off, causing a woman to suffer a pulmonary embolism which has resulted in fragments of the device remaining in her heart.